ClearPoint Neuro, Inc.
CLPT
$12.97
-$0.14-1.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.89M | -5.84M | -6.03M | -5.39M | -4.97M |
| Total Depreciation and Amortization | 426.00K | 626.00K | 334.00K | 471.00K | 495.00K |
| Total Amortization of Deferred Charges | 39.00K | 21.00K | -- | 0.00 | 22.00K |
| Total Other Non-Cash Items | 2.34M | 2.44M | 2.13M | 1.91M | 1.90M |
| Change in Net Operating Assets | -35.00K | 197.00K | -2.61M | 1.76M | 1.35M |
| Cash from Operations | -3.12M | -2.55M | -6.17M | -1.24M | -1.20M |
| Capital Expenditure | -199.00K | -91.00K | -183.00K | -263.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -199.00K | -91.00K | -183.00K | -263.00K | -12.00K |
| Total Debt Issued | 0.00 | 28.65M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -10.00M |
| Issuance of Common Stock | 0.00 | 3.60M | 21.00K | 121.00K | 0.00 |
| Repurchase of Common Stock | 0.00 | -356.00K | -1.31M | -84.00K | -61.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 78.00K | -78.00K | -- | -- |
| Cash from Financing | 0.00 | 31.98M | -1.36M | 37.00K | -10.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.32M | 29.33M | -7.72M | -1.47M | -11.27M |